Cargando…
Early detection and stratification of lung cancer aided by a cost-effective assay targeting circulating tumor DNA (ctDNA) methylation
BACKGROUND: Detection of lung cancer at earlier stage can greatly improve patient survival. We aim to develop, validate, and implement a cost-effective ctDNA-methylation-based plasma test to aid lung cancer early detection. METHODS: Case-control studies were designed to select the most relevant mark...
Autores principales: | Wang, Zhoufeng, Xie, Kehui, Zhu, Guonian, Ma, Chengcheng, Cheng, Cheng, Li, Yangqian, Xiao, Xue, Li, Chengpin, Tang, Jun, Wang, Hui, Su, Zhixi, Liu, Dan, Zhang, Wengeng, Huang, Yan, Tang, Huairong, Liu, Rui, Li, Weimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276518/ https://www.ncbi.nlm.nih.gov/pubmed/37330511 http://dx.doi.org/10.1186/s12931-023-02449-8 |
Ejemplares similares
-
Single-Cell Transcriptomics of Immune Cells Reveal Diversity and Exhaustion Signatures in Non-Small-Cell Lung Cancer
por: Zhao, Ying, et al.
Publicado: (2022) -
The circulating tumor DNA (ctDNA) alteration level predicts therapeutic response in metastatic breast cancer: Novel prognostic indexes based on ctDNA
por: Liu, Binliang, et al.
Publicado: (2022) -
Clinical factors associated with circulating tumor DNA (ctDNA) in primary breast cancer
por: Zhou, Yidong, et al.
Publicado: (2019) -
Circulating tumor DNA (ctDNA) in the era of personalized cancer therapy
por: Khatami, Fatemeh, et al.
Publicado: (2018) -
Liquid Biopsy-Analysis of Circulating Tumor DNA (ctDNA) in Bladder Cancer
por: Todenhöfer, Tilman, et al.
Publicado: (2018)